null - FindTrial

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2013-002982-20-FI

Enrollment

Registered

2013-07-16

Start date

2013-08-28

Completion date

Unknown

Last updated

2013-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: LLT Classification code 10054711 Term: Postoperative pain System Organ Class: 100000004863 MedDRA version: 14.1 Level: LLT Classification code 10049130 Term: Back surgery System Organ Class: 100000004865

Interventions

Trade Name: Ketesse Product Name: Ketesse Pharmaceutical Form: Injection INN or Proposed INN: DEXKETOPROFEN (AS TROMETAMOL) Pharmaceutical form of the placebo: Injection Route of administration of the

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 60 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 30

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Contacts

Public ContactKuopion yliopistollinen sairaala

Merja Kokki

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026